TUCKER, GA -- USPOULTRY and the USPOULTRY Foundation announce the completion of a funded research project at North Carolina State University in Raleigh, N.C., that evaluated a new vaccine to protect again two important diseases. The project is part of the Association’s comprehensive research program encompassing all phases of poultry and egg production and processing. A brief summary of the completed project is shown below. A complete report, along with information on other Association research, may be obtained by going to USPOULTRY’s website, www.uspoultry.org. The project summary is as follows:
Project #676: Biological Characterization of a Serotype 1 Marek’s Disease Virus-vectored Bi-valent Vaccine for Infectious Laryngotracheitis and Marek’s Disease. (Dr. Isabel Gimeno, Dr. James Guy, Dr. Robert Silva and Dr. Henry Hunt; North Carolina State University in Raleigh, N.C.)
The research project, led by Dr. Isabel Gimeno and Dr. James Guy at North Carolina State University, evaluated a new vaccine candidate which could be valuable for protecting chickens against both Marek’s disease and infectious laryngotracheitis. The new recombinant vaccine is a Marek’s disease virus into which genes of infectious laryngotracheitis virus have been inserted. The new vaccine shows potential advantages over existing vaccines. The results open a new avenue in the development of recombinant vaccines for use in poultry.
For a detailed summary, click here.
U.S. Poultry & Egg Association is the all-feather organization representing the complete spectrum of today’s poultry industry, whose mission is to progressively serve member companies through research, education, communication, and technical assistance. Founded in 1947, U.S. Poultry & Egg Association is based in Tucker, GA.